Jeffrey M. Vainshtein

Author

Also Known As

J. M. Vainshtein, J. Vainshtein, J.M. Vainshtein, Jacklyn Vainshtein, Jeffrey M Vainshtein, Jeffrey M. Vainshtein, Jeffrey Vainshtein

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Michigan Michigan Medicine Albert Einstein College of Medicine Apple (Israel)Montefiore Medical Center

About

Jeffrey M. Vainshtein is an author at University of Michigan specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	486
2	Health Sciences	7	7	352
3	Pathology	2	2	93
4	Cell Biology	1	1	11
5	Hepatology	1	1	28

Jeffrey M. Vainshtein

Publications

966

Citations

H-Index

Page 1

	Year	Citations
Characterization of Human Immunodeficiency Virus Type 1 Monomeric and Trimeric gp120 Glycoproteins Stabilized in the CD4-Bound State: Antigenicity, Biophysics, and Immunogenicity Barna Dey, Marie Pancera, Krisha Svehla, Journal of Virology	2007	106
Long-Term Quality of Life After Swallowing and Salivary-Sparing Chemo–Intensity Modulated Radiation Therapy in Survivors of Human Papillomavirus–Related Oropharyngeal Cancer Jeffrey M. Vainshtein, Dominic H. Moon, Felix Y. Feng, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineOncologyLong-term QualityRadiation TherapyCancer Management	2015	101
Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer Jeffrey M. Vainshtein, Matthew E. Spector, Matthew H. Stenmark, Oral Oncology Locoregional FailureMedicineNeck OncologyPost-chemoradiotherapy F-18-fdg Pet/ctOncology	2014	70
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer Jeffrey M. Vainshtein, Matthew E. Spector, Jonathan B. McHugh, Oral Oncology Locoregional FailureCancer-associated VirusMedicineHead And Neck CancerOncology	2014	69
Outcomes and prognostic factors in modern era management of major salivary gland cancer N. Jegadeesh, Yuan Liu, Roshan S. Prabhu, Oral Oncology Prognostic FactorsModern Era ManagementMedicineCancer ManagementPathology	2015	65
Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy Jeffrey M. Vainshtein, Eyad Abu‐Isa, Karin Olson, Radiation Oncology	2012	57
Patient-Reported Voice and Speech Outcomes After Whole-Neck Intensity Modulated Radiation Therapy and Chemotherapy for Oropharyngeal Cancer: Prospective Longitudinal Study Jeffrey M. Vainshtein, Kent A. Griffith, Felix Y. Feng, International Journal of Radiation OncologyBiologyPhysics Patient-reported VoiceProspective Longitudinal StudyVoiceRadiation TherapyMedicine	2014	48
Matted nodes: High distant‐metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus–related oropharyngeal cancer Jeffrey M. Vainshtein, Matthew E. Spector, Mohannad Ibrahim, Head & Neck	2015	46
Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy C. Demiroz, Jeffrey M. Vainshtein, Georgios Koukourakis, Head & Neck	2013	45
Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States Matthew H. Stenmark, Dean A. Shumway, Cui Guo, The Laryngoscope	2017	43

Page 1